oxonic acid has been researched along with Carcinoma, Anaplastic in 39 studies
Oxonic Acid: Antagonist of urate oxidase.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study evaluated long-term outcomes for patients who received adjuvant gemcitabine plus S-1 chemotherapy after resection for pancreatic carcinoma." | 9.16 | Long-term results of adjuvant gemcitabine plus S-1 chemotherapy after surgical resection for pancreatic carcinoma. ( Hashimoto, Y; Kondo, N; Murakami, Y; Nakagawa, N; Nakashima, A; Sudo, T; Sueda, T; Uemura, K, 2012) |
| "In the current study, we have evaluated the clinical and immunological responses in patients with advanced pancreatic carcinoma who received dendritic cell (DC)-based immunotherapy in combination with gemcitabine and/or S-1." | 7.78 | Clinical and immunologic evaluation of dendritic cell-based immunotherapy in combination with gemcitabine and/or S-1 in patients with advanced pancreatic carcinoma. ( Homma, S; Imai, K; Kimura, Y; Koido, S; Okamoto, M; Shimamura, K; Shimodaira, S; Sunamura, M; Takahashi, H; Tomoda, T; Tsukada, J; Yonemitsu, Y, 2012) |
| "The aim of this study was to evaluate the efficacy of adjuvant gemcitabine plus S-1 chemotherapy after aggressive surgical resection for advanced biliary carcinoma." | 7.75 | Adjuvant gemcitabine plus S-1 chemotherapy improves survival after aggressive surgical resection for advanced biliary carcinoma. ( Hashimoto, Y; Hayashidani, Y; Murakami, Y; Nakamura, H; Nakashima, A; Sudo, T; Sueda, T; Uemura, K, 2009) |
| "A multicenter randomized trial was performed comparing oral tegafur/gimeracil/oteracil (S-1) and uracil-tegafur/ leucovorin (UFT/LV) as adjuvant therapy for stage III colorectal cancer." | 5.22 | Tumor 5-FU-related mRNA Expression and Efficacy of Oral Fluoropyrimidines in Adjuvant Chemotherapy of Colorectal Cancer. ( Kaiho, T; Kobayashi, S; Koda, K; Kosugi, C; Maruyama, T; Matsubara, H; Miyauchi, H; Takiguchi, N, 2016) |
| "This study evaluated long-term outcomes for patients who received adjuvant gemcitabine plus S-1 chemotherapy after resection for pancreatic carcinoma." | 5.16 | Long-term results of adjuvant gemcitabine plus S-1 chemotherapy after surgical resection for pancreatic carcinoma. ( Hashimoto, Y; Kondo, N; Murakami, Y; Nakagawa, N; Nakashima, A; Sudo, T; Sueda, T; Uemura, K, 2012) |
| "We examined the completion rate, safety, and adverse events in patients with T2N0 glottic carcinoma who received chemoradiotherapy with S-1 (tegafur-gimeracil-oteracil potassium)." | 3.80 | Radiotherapy concurrent with S-1 and radiotherapy alone for T2N0 glottic carcinoma: a retrospective comparative study. ( Higashino, M; Ichihara, S; Kawata, R; Lee, K; Nishikawa, S; Uesugi, Y, 2014) |
| "In the current study, we have evaluated the clinical and immunological responses in patients with advanced pancreatic carcinoma who received dendritic cell (DC)-based immunotherapy in combination with gemcitabine and/or S-1." | 3.78 | Clinical and immunologic evaluation of dendritic cell-based immunotherapy in combination with gemcitabine and/or S-1 in patients with advanced pancreatic carcinoma. ( Homma, S; Imai, K; Kimura, Y; Koido, S; Okamoto, M; Shimamura, K; Shimodaira, S; Sunamura, M; Takahashi, H; Tomoda, T; Tsukada, J; Yonemitsu, Y, 2012) |
| "The aim of this study was to evaluate the efficacy of adjuvant gemcitabine plus S-1 chemotherapy after aggressive surgical resection for advanced biliary carcinoma." | 3.75 | Adjuvant gemcitabine plus S-1 chemotherapy improves survival after aggressive surgical resection for advanced biliary carcinoma. ( Hashimoto, Y; Hayashidani, Y; Murakami, Y; Nakamura, H; Nakashima, A; Sudo, T; Sueda, T; Uemura, K, 2009) |
| "Irinotecan was administered intravenously over the course of 90 minutes on day 1, and S-1 was given orally in 2 divided doses from days 1 to 14 of a 21-day cycle." | 2.82 | Phase I Clinical Study of Irinotecan Plus S-1 in Patients With Advanced or Recurrent Cervical Cancer Previously Treated With Platinum-Based Chemotherapy. ( Kimura, T; Kobayashi, E; Kozasa, K; Mabuchi, S; Owa, T; Tomimatsu, T; Tsutui, T; Yamashita, M; Yoki, T; Yokoi, E, 2016) |
| "The response rate of S-1 for colorectal cancer is high, ranging from 35% to 40%." | 2.75 | Phase II study of S-1 plus leucovorin in patients with metastatic colorectal cancer. ( Boku, N; Furuhata, T; Hyodo, I; Kato, T; Koizumi, W; Miyashita, K; Miyata, Y; Nishina, T; Okada, Y; Sawaki, A; Toh, Y; Yamaguchi, K, 2010) |
| "G-CSF producing anaplastic carcinoma of the pancreas is extremely rare and there are no reports with regard to response evaluation by FDG-PET." | 2.49 | [An autopsy of G-CSF-producing anaplastic carcinoma of the pancreas with impaired accumulation on FDG-PET after S-1 chemotherapy]. ( Ikeda, S; Ito, T; Kanazawa, H; Katada, N; Morita, K; Narita, M; Nishimura, D; Okubo, K; Shibahara, H; Takeuchi, A, 2013) |
| "We diagnosed advanced gastric cancer with disseminated carcinomatosis of the bone marrow and multiple bone metastasis." | 2.47 | [A very elderly case of advanced gastric cancer with disseminated carcinomatosis of bone marrow and multiple bone metastasis, diagnosed by extremely elevated serum alkaline phosphatase levels, and treated with low-dose S-1 to avoid disseminated intravascu ( Ashida, C; Higashida, A; Kawara, F; Kondo, T; Mamori, S; Okutani, T; Onishi, K; Takeda, A; Yamada, H, 2011) |
| "Prognosis of patients with metastatic gastric cancer is abysmal, usually just a few months." | 1.40 | [Case report of a patient with advanced and disseminated gastric carcinoma treated by s-1]. ( Katolická, J; Rotnáglová, S; Vaníček, J, 2014) |
| " Most adverse events were mild." | 1.40 | Safety and efficacy of S-1 chemotherapy in recurrent and metastatic nasopharyngeal carcinoma patients after failure of platinum-based chemotherapy: multi-institutional retrospective analysis. ( Chen, ZB; Cheng, H; Lin, Z; Liu, YM; Ou, XQ; Peng, PJ; Tang, YN; Wang, SY; Wu, X; Zeng, LJ; Zhang, HY, 2014) |
| "Twenty-eight patients with advanced gastric cancer underwent gastrectomy without preoperative chemotherapy." | 1.39 | Adjuvant chemotherapy with S-1 followed by docetaxel for gastric cancer and CY1P0 peritoneal metastasis after relatively curative surgery. ( Fujita, I; Kanazawa, Y; Kato, S; Onodera, H; Uchida, E, 2013) |
| "Although disseminated carcinomatosis of the bone marrow is associated with a poor prognosis, we believe that the duration of survival of our patient was extended due to initiation of chemotherapy at an early stage." | 1.39 | [A case of gastric cancer accompanied by disseminated carcinomatosis of the bone marrow successfully controlled by S-1 and cisplatin combination therapy]. ( Amagasa, H; Ami, K; Ando, M; Aoki, N; Arai, K; Fujiya, K; Fukuda, A; Ganno, H; Imai, K; Kamikozuru, H; Nagahama, T; Ohbu, M; Takeuchi, S; Tei, S, 2013) |
| "Thymic carcinoma is a rare intrathoracic malignant tumor, and the prognosis for patients with advanced stage of the disease is poor." | 1.36 | S-1 is an active anticancer agent for advanced thymic carcinoma. ( Hosomi, Y; Iguchi, M; Okamura, T; Okuma, Y; Shibuya, M; Shimokawa, T; Takagi, Y, 2010) |
| "We report a case of anaplastic carcinoma of the thyroid administered peroral fluorinated pyrimidine, providing longterm survival during three years." | 1.35 | [A case of anaplastic carcinoma of thyroid administered peroral fluorinated pyrimidine for long-term survival during three years]. ( Kira, M; Takizawa, H; Tangoku, A; Toba, H; Yamai, H; Yoshida, T, 2009) |
| "We diagnosed disseminated carcinomatosis of bone marrow by gastric cancer." | 1.35 | [A case of advanced gastric cancer with disseminated carcinomatosis of bone marrow treated by S-1 and CDDP]. ( Fujishima, Y; Fukuda, T; Fukunaga, H; Iwai, M; Koide, M; Miura, M; Yoneda, R, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 11 (28.21) | 29.6817 |
| 2010's | 26 (66.67) | 24.3611 |
| 2020's | 2 (5.13) | 2.80 |
| Authors | Studies |
|---|---|
| Itano, O | 1 |
| Takemura, Y | 1 |
| Kishida, N | 1 |
| Tamagawa, E | 1 |
| Shinozaki, H | 1 |
| Ikeda, K | 1 |
| Urakami, H | 1 |
| Ei, S | 1 |
| Hayatsu, S | 1 |
| Suzuki, K | 1 |
| Sakuragawa, T | 1 |
| Ishii, M | 1 |
| Shito, M | 1 |
| Aiura, K | 1 |
| Fujisaki, H | 1 |
| Takano, K | 1 |
| Matsui, J | 1 |
| Minagawa, T | 1 |
| Shinoda, M | 1 |
| Kitago, M | 1 |
| Abe, Y | 1 |
| Yagi, H | 1 |
| Oshima, G | 1 |
| Hori, S | 1 |
| Kitagawa, Y | 2 |
| Imaoka, H | 1 |
| Ikeda, M | 2 |
| Maehara, K | 1 |
| Umemoto, K | 1 |
| Ozaka, M | 1 |
| Kobayashi, S | 2 |
| Terashima, T | 1 |
| Inoue, H | 1 |
| Sakaguchi, C | 1 |
| Tsuji, K | 2 |
| Shioji, K | 1 |
| Okamura, K | 1 |
| Kawamoto, Y | 1 |
| Suzuki, R | 1 |
| Shirakawa, H | 1 |
| Nagano, H | 1 |
| Ueno, M | 1 |
| Morizane, C | 2 |
| Furuse, J | 2 |
| Doi, T | 1 |
| Sakamoto, T | 1 |
| Okino, T | 1 |
| Ikeda, S | 1 |
| Okubo, K | 1 |
| Shibahara, H | 1 |
| Narita, M | 1 |
| Morita, K | 1 |
| Takeuchi, A | 1 |
| Kanazawa, H | 1 |
| Ito, T | 1 |
| Nishimura, D | 1 |
| Katada, N | 1 |
| Tsuya, A | 1 |
| Kurata, T | 1 |
| Tamiya, A | 1 |
| Okamoto, I | 2 |
| Ueda, S | 1 |
| Sakai, D | 1 |
| Sugimoto, N | 1 |
| Matsumoto, K | 2 |
| Goto, I | 1 |
| Yamamoto, N | 1 |
| Fukuoka, M | 2 |
| Nakagawa, K | 2 |
| Kanazawa, Y | 1 |
| Kato, S | 1 |
| Fujita, I | 1 |
| Onodera, H | 1 |
| Uchida, E | 1 |
| Ganno, H | 1 |
| Nagahama, T | 1 |
| Fukuda, A | 1 |
| Takeuchi, S | 1 |
| Fujiya, K | 1 |
| Amagasa, H | 1 |
| Kamikozuru, H | 1 |
| Imai, K | 2 |
| Ami, K | 1 |
| Aoki, N | 1 |
| Ando, M | 1 |
| Arai, K | 1 |
| Tei, S | 1 |
| Ohbu, M | 1 |
| Fujisawa, Y | 1 |
| Fujimoto, M | 1 |
| Higashino, M | 1 |
| Kawata, R | 1 |
| Lee, K | 1 |
| Nishikawa, S | 1 |
| Ichihara, S | 1 |
| Uesugi, Y | 1 |
| Katolická, J | 1 |
| Rotnáglová, S | 1 |
| Vaníček, J | 1 |
| Peng, PJ | 1 |
| Cheng, H | 1 |
| Ou, XQ | 1 |
| Zeng, LJ | 1 |
| Wu, X | 1 |
| Liu, YM | 1 |
| Lin, Z | 1 |
| Tang, YN | 1 |
| Wang, SY | 1 |
| Zhang, HY | 1 |
| Chen, ZB | 1 |
| Murakami, Y | 4 |
| Uemura, K | 4 |
| Sudo, T | 4 |
| Hashimoto, Y | 4 |
| Kondo, N | 3 |
| Nakagawa, N | 2 |
| Sasaki, H | 1 |
| Sueda, T | 4 |
| Yoshida, M | 1 |
| Muro, K | 1 |
| Tsuji, A | 2 |
| Hamamoto, Y | 1 |
| Yoshino, T | 1 |
| Yoshida, K | 1 |
| Shirao, K | 1 |
| Miyata, Y | 2 |
| Takahari, D | 1 |
| Takahashi, T | 1 |
| Ohtsu, A | 1 |
| Hayashi, H | 1 |
| Eguchi, N | 1 |
| Sumimoto, K | 1 |
| Azakami, T | 1 |
| Sumida, T | 1 |
| Tamura, T | 1 |
| Sumii, M | 1 |
| Uraoka, N | 1 |
| Shimamoto, F | 1 |
| Mabuchi, S | 1 |
| Yokoi, E | 1 |
| Owa, T | 1 |
| Kozasa, K | 1 |
| Yamashita, M | 1 |
| Kobayashi, E | 1 |
| Tomimatsu, T | 1 |
| Yoki, T | 1 |
| Tsutui, T | 1 |
| Kimura, T | 1 |
| Koda, K | 1 |
| Miyauchi, H | 1 |
| Kosugi, C | 1 |
| Kaiho, T | 1 |
| Takiguchi, N | 1 |
| Maruyama, T | 2 |
| Matsubara, H | 1 |
| Yamai, H | 1 |
| Yoshida, T | 1 |
| Toba, H | 1 |
| Kira, M | 1 |
| Takizawa, H | 1 |
| Tangoku, A | 1 |
| Tanigawa, T | 1 |
| Miyamoto, Y | 1 |
| Abe, M | 1 |
| Hasuo, T | 1 |
| Doiguchi, M | 1 |
| Sakamoto, F | 1 |
| Koizumi, W | 1 |
| Boku, N | 1 |
| Yamaguchi, K | 1 |
| Sawaki, A | 1 |
| Kato, T | 1 |
| Toh, Y | 1 |
| Hyodo, I | 1 |
| Nishina, T | 1 |
| Furuhata, T | 1 |
| Miyashita, K | 1 |
| Okada, Y | 1 |
| Hayashidani, Y | 1 |
| Nakamura, H | 1 |
| Nakashima, A | 3 |
| Fujishima, Y | 1 |
| Yoneda, R | 1 |
| Iwai, M | 1 |
| Fukunaga, H | 1 |
| Miura, M | 1 |
| Koide, M | 1 |
| Fukuda, T | 1 |
| Tanizaki, J | 1 |
| Takezawa, K | 1 |
| Tsukioka, S | 1 |
| Uchida, J | 1 |
| Kiniwa, M | 1 |
| Hashiguchi, K | 1 |
| Kitajima, Y | 1 |
| Kai, K | 1 |
| Hiraki, M | 1 |
| Nakamura, J | 1 |
| Tokunaga, O | 1 |
| Noshiro, H | 1 |
| Miyazaki, K | 1 |
| Yoon, DH | 1 |
| Cho, Y | 1 |
| Kim, SY | 1 |
| Nam, SY | 1 |
| Choi, SH | 1 |
| Roh, JL | 1 |
| Lee, SW | 1 |
| Song, SY | 1 |
| Lee, JH | 1 |
| Kim, JS | 1 |
| Cho, KJ | 1 |
| Kim, SB | 1 |
| Okuma, Y | 1 |
| Shimokawa, T | 1 |
| Takagi, Y | 1 |
| Hosomi, Y | 1 |
| Iguchi, M | 1 |
| Okamura, T | 1 |
| Shibuya, M | 1 |
| Kogashiwa, Y | 1 |
| Yamauchi, K | 1 |
| Nagafuji, H | 1 |
| Matsuda, T | 1 |
| Tsubosaka, T | 1 |
| Karaho, T | 1 |
| Kohno, N | 1 |
| Yabe, N | 1 |
| Murai, S | 1 |
| Akatsu, T | 1 |
| Shoji, T | 1 |
| Shimizu, H | 1 |
| Fukushima, H | 1 |
| Mitsugi, Y | 1 |
| Ishida, T | 1 |
| Amemiya, T | 1 |
| Hasegawa, H | 1 |
| Kimura, Y | 1 |
| Tsukada, J | 1 |
| Tomoda, T | 1 |
| Takahashi, H | 1 |
| Shimamura, K | 1 |
| Sunamura, M | 1 |
| Yonemitsu, Y | 1 |
| Shimodaira, S | 1 |
| Koido, S | 1 |
| Homma, S | 1 |
| Okamoto, M | 1 |
| Takeda, A | 1 |
| Kawara, F | 1 |
| Onishi, K | 1 |
| Higashida, A | 1 |
| Mamori, S | 1 |
| Ashida, C | 1 |
| Okutani, T | 1 |
| Yamada, H | 1 |
| Kondo, T | 1 |
| Sakabe, R | 1 |
| Ohge, H | 1 |
| Hiyama, E | 1 |
| Doyama, H | 1 |
| Yamada, S | 1 |
| Kaneko, Y | 1 |
| Takemura, K | 1 |
| Tsuji, S | 1 |
| Tominaga, K | 1 |
| Inagaki, S | 1 |
| Hayashi, T | 1 |
| Ito, R | 1 |
| Nakanishi, H | 2 |
| Kitou, Y | 1 |
| Takeda, Y | 1 |
| Yamamoto, M | 1 |
| Inaki, N | 1 |
| Yamada, T | 1 |
| Niwa, H | 1 |
| Katayanagi, K | 1 |
| Kurumaya, H | 1 |
| Mochizuki, Y | 1 |
| Kodera, Y | 1 |
| Ito, S | 1 |
| Yamamura, Y | 1 |
| Ito, K | 1 |
| Akiyama, S | 1 |
| Nakao, A | 1 |
| Tatematsu, M | 1 |
| Takahashi, K | 1 |
| Miyagawa, K | 1 |
| Mitachi, Y | 2 |
| Masuda, T | 1 |
| Oogoshi, T | 1 |
| Kawami, H | 1 |
| Shigematsu, H | 1 |
| Fujimoto, Y | 1 |
| Ishigami, S | 1 |
| Nakajo, A | 1 |
| Uenosono, Y | 1 |
| Okumura, H | 1 |
| Matsumoto, M | 1 |
| Arigami, T | 1 |
| Uchikado, Y | 1 |
| Setoyama, T | 1 |
| Hokita, S | 1 |
| Natsugoe, S | 1 |
| Aikou, T | 1 |
| Okusaka, T | 1 |
| Ito, Y | 1 |
| Ueno, H | 1 |
| Ishii, H | 1 |
| Kawashima, M | 1 |
| Kagami, Y | 1 |
| Ikeda, H | 1 |
| Morita, S | 1 |
| Nakata, B | 1 |
| Shirasaka, T | 1 |
| Saji, S | 1 |
| Ohashi, Y | 1 |
| Sakamoto, J | 1 |
| Hirakawa, K | 1 |
| Kim, YH | 1 |
| Seo, HY | 1 |
| Jeen, YT | 1 |
| Kim, HK | 1 |
| Shim, BY | 1 |
| Yang, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| PD-1 Antibody Plus Gemcitabine and Oxaliplatin (GEMOX) as Postoperative Adjuvant Therapy in Perihilar Cholangiocarcinoma Patients With Positively Metastatic Lymph Nodes : a Single Arm, Phase II Trial[NCT05430698] | Phase 2 | 62 participants (Anticipated) | Interventional | 2023-01-31 | Recruiting | ||
| Phase II Study of S-1 Plus Leucovorin (1 Week on and 1 Week Off) as First-line Treatment for Patients With Metastatic and Recurrent Gastric Cancer[NCT02090153] | Phase 2 | 39 participants (Actual) | Interventional | 2011-07-31 | Completed | ||
| A Phase II Study Assessing Efficacy and Safety of TS-1 in Combination With Calcium Folinate in Patients With Heavily Pre-treated Metastatic Colorectal Cancer[NCT03517618] | Phase 2 | 41 participants (Actual) | Interventional | 2014-07-05 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for oxonic acid and Carcinoma, Anaplastic
| Article | Year |
|---|---|
[An autopsy of G-CSF-producing anaplastic carcinoma of the pancreas with impaired accumulation on FDG-PET after S-1 chemotherapy].
Topics: Aged; Antimetabolites, Antineoplastic; Autopsy; Carcinoma; Drug Combinations; Fatal Outcome; Female; | 2013 |
Autopsy of anaplastic carcinoma of the pancreas producing granulocyte colony-stimulating factor.
Topics: Antineoplastic Combined Chemotherapy Protocols; Autopsy; Biopsy; Carcinoma; Deoxycytidine; Drug Comb | 2016 |
[A very elderly case of advanced gastric cancer with disseminated carcinomatosis of bone marrow and multiple bone metastasis, diagnosed by extremely elevated serum alkaline phosphatase levels, and treated with low-dose S-1 to avoid disseminated intravascu
Topics: Aged, 80 and over; Alkaline Phosphatase; Antimetabolites, Antineoplastic; Bone Marrow Neoplasms; Bon | 2011 |
10 trials available for oxonic acid and Carcinoma, Anaplastic
| Article | Year |
|---|---|
A phase II study of cisplatin /S-1 in patients with carcinomas of unknown primary site.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Carcinoma; Cisplatin; Drug Combinat | 2013 |
Combination chemotherapy with bevacizumab and S-1 for elderly patients with metastatic colorectal cancer (BASIC trial).
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Pro | 2015 |
Phase I Clinical Study of Irinotecan Plus S-1 in Patients With Advanced or Recurrent Cervical Cancer Previously Treated With Platinum-Based Chemotherapy.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Ca | 2016 |
Tumor 5-FU-related mRNA Expression and Efficacy of Oral Fluoropyrimidines in Adjuvant Chemotherapy of Colorectal Cancer.
Topics: Administration, Oral; Adult; Aged; Antimetabolites, Antineoplastic; Carcinoma; Chemotherapy, Adjuvan | 2016 |
Phase II study of S-1 plus leucovorin in patients with metastatic colorectal cancer.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Colore | 2010 |
Phase II study of S-1 plus leucovorin in patients with metastatic colorectal cancer.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Colore | 2010 |
Phase II study of S-1 plus leucovorin in patients with metastatic colorectal cancer.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Colore | 2010 |
Phase II study of S-1 plus leucovorin in patients with metastatic colorectal cancer.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Colore | 2010 |
Phase I study of S-1 plus nedaplatin in patients with advanced/recurrent head and neck cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Carcinoma, Squamous Cell; Cisplatin | 2010 |
Long-term results of adjuvant gemcitabine plus S-1 chemotherapy after surgical resection for pancreatic carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Analysis of Variance; Antimetabolites, Antineoplasti | 2012 |
A phase I trial of S-1 with concurrent radiotherapy for locally advanced pancreatic cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Combined Modality Therapy; Dose-Res | 2007 |
A phase I study of combination therapy of the oral fluorinated pyrimidine compound S-1 with low-dose cisplatin twice-a-week administration (JFMC27-9902 Step2) in patients with advanced gastric cancer using a continual reassessment method.
Topics: Administration, Oral; Adult; Aged; Algorithms; Antimetabolites, Antineoplastic; Antineoplastic Combi | 2007 |
Phase I dose escalation study of docetaxel with a fixed dose of S-1 in combination chemotherapy for advanced gastric cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Docetaxel; Dose-Response Rel | 2009 |
26 other studies available for oxonic acid and Carcinoma, Anaplastic
| Article | Year |
|---|---|
A prospective feasibility study of one-year administration of adjuvant S-1 therapy for resected biliary tract cancer in a multi-institutional trial (Tokyo Study Group for Biliary Cancer: TOSBIC01).
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Ampulla of Vater; Bile Duct Neoplasms; Carcino | 2020 |
Clinical outcomes of chemotherapy in patients with undifferentiated carcinoma of the pancreas: a retrospective multicenter cohort study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Deoxycyti | 2020 |
[Pulmonary Metastasis of Gastric Cancer as Carcinomatous Lymphangiosis at Five and Half Years after Surgery;Report of a Case].
Topics: Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Carcinoma; Chemotherapy, Adjuvant; Doc | 2018 |
Adjuvant chemotherapy with S-1 followed by docetaxel for gastric cancer and CY1P0 peritoneal metastasis after relatively curative surgery.
Topics: Administration, Intravenous; Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy | 2013 |
[A case of gastric cancer accompanied by disseminated carcinomatosis of the bone marrow successfully controlled by S-1 and cisplatin combination therapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Carcinoma; Cisplatin; D | 2013 |
Metastatic cutaneous apocrine carcinoma of the axilla successfully treated using systemic chemotherapy with i.v. epirubicin and cyclophosphamide followed by oral fluorinated pyrimidine.
Topics: Adult; Antineoplastic Agents; Axilla; Carcinoma; Cyclophosphamide; Drug Combinations; Epirubicin; Hu | 2014 |
Radiotherapy concurrent with S-1 and radiotherapy alone for T2N0 glottic carcinoma: a retrospective comparative study.
Topics: Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Carcinoma; Chemoradiotherapy; Drug Combina | 2014 |
[Case report of a patient with advanced and disseminated gastric carcinoma treated by s-1].
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy P | 2014 |
Safety and efficacy of S-1 chemotherapy in recurrent and metastatic nasopharyngeal carcinoma patients after failure of platinum-based chemotherapy: multi-institutional retrospective analysis.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Carcinoma; Disease Progression; Drug Combinations; Fem | 2014 |
Is pancreatic fistula associated with worse overall survival in patients with pancreatic carcinoma?
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Chemother | 2015 |
[A case of anaplastic carcinoma of thyroid administered peroral fluorinated pyrimidine for long-term survival during three years].
Topics: Administration, Oral; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Pr | 2009 |
[A case of inflammatory carcinoma, well-controlled by chemotherapy, especially, vinorelbine, S-1 and trastuzumab].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antimetabolites, Antineoplastic; Antineop | 2009 |
Adjuvant gemcitabine plus S-1 chemotherapy improves survival after aggressive surgical resection for advanced biliary carcinoma.
Topics: Aged; Antimetabolites, Antineoplastic; Biliary Tract Neoplasms; Carcinoma; Chemotherapy, Adjuvant; D | 2009 |
[A case of advanced gastric cancer with disseminated carcinomatosis of bone marrow treated by S-1 and CDDP].
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplas | 2009 |
Synergistic antitumor effect of S-1 and HER2-targeting agents in gastric cancer with HER2 amplification.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemothe | 2010 |
A quantitative evaluation of the determinant proteins for S-1 responsiveness in a biopsy specimen assists in patient selection to neoadjuvant therapy in cases of advanced gastric cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Pharmaco | 2010 |
Usefulness of interim FDG-PET after induction chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck receiving sequential induction chemotherapy followed by concurrent chemoradiotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Carcinoma, Squamous Cell; Ci | 2011 |
S-1 is an active anticancer agent for advanced thymic carcinoma.
Topics: Aged; Antimetabolites, Antineoplastic; Carcinoma; Disease Progression; Disease-Free Survival; Drug C | 2010 |
[A case of advanced gastric cancer resistant to S-1 successfully treated with weekly administration of paclitaxel].
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Carcinoma; Drug | 2010 |
Clinical and immunologic evaluation of dendritic cell-based immunotherapy in combination with gemcitabine and/or S-1 in patients with advanced pancreatic carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols | 2012 |
Prognostic significance of telomerase activity and human telomerase reverse transcriptase expression in ampullary carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Ampulla of Vater; Antineoplastic Agents; Biomarkers, Tumor; Carcinom | 2012 |
[A case of disseminated carcinomatosis of bone marrow treated by S-1 and cisplatin after distal gastrectomy for early gastric cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Carcinoma; Cisplatin; Dissemi | 2012 |
Chemosensitivity of peritoneal micrometastases as evaluated using a green fluorescence protein (GFP)-tagged human gastric cancer cell line.
Topics: Administration, Oral; Animals; Antimetabolites, Antineoplastic; Ascites; Carcinoma; Cell Count; Dose | 2003 |
[A case of gastric cancer with metastasis to cervical lymph nodes and pulmonary lymphangitis carcinomatosa responding to neoadjuvant chemotherapy with TS-1 and CDDP].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Drug Combinations; Gastrectomy | 2003 |
[A case of advanced gastric carcinoma successfully treated with TS-1/CDDP as a neoadjuvant chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Chemotherapy, Adjuvant; Cisplatin; | 2003 |
[Clinical efficacy of biweekly paclitaxel and S-1 regimen for 14 gastric cancer patients with liver metastases].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Drug Administration Schedule; Drug | 2007 |